Cheaper plasma treatment may rival albumin for kidney swelling in kids
NCT ID NCT07685093
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study compares two treatments—albumin and fresh frozen plasma—for children with idiopathic nephrotic syndrome who have fluid buildup that doesn't respond to standard diuretics. The goal is to see which approach resolves swelling faster and more safely. Fifty-six children aged 2 to 12 will receive one of the two treatments alongside a diuretic, and researchers will track how quickly edema improves, hospital stay length, and any complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Human albumin 20% and fresh frozen plasma
- What this could lead to
- If one treatment works better, it could offer a safer or cheaper way to reduce swelling in children with nephrotic syndrome.
- What could go wrong
- This is a small, early-stage study with only 56 children, so results may not apply broadly. Both treatments carry risks like infection or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC NEPHROTIC SYNDROME (INS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••